Full Text AA-95-005 ROLE OF TOBACCO DEPENDENCE IN ALCOHOLISM TREATMENT NIH GUIDE, Volume 24, Number 24, June 30, 1995 RFA: AA-95-005 P.T. 34 Keywords: Alcohol/Alcoholism Addiction Smoking Behavior Treatment, Medical+ National Institute On Alcohol Abuse And Alcoholism Letter of Intent Receipt Date: October 18, 1995 Application Receipt Date: November 21, 1995 PURPOSE The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is seeking research applications to study the alcohol tobacco interaction in its implications for alcoholism treatment. The objective of this RFA is to encourage research that will lead to improved strategies for treating alcohol and nicotine dependence in patients receiving care for problem drinking. Such research may identify and test relevant clinical intervention strategies; identify interactions between the two substances that have implications for relapse prevention, or further understanding of the alcoholism treatment process by investigating reinforcement mechanisms underlying conjoint abuse of the two substances. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This Request for Applications (RFA), is related to the priority areas of alcohol abuse reduction and alcoholism treatment. Potential applicants may obtain a copy of Healthy People 2000 (Full Report: Stock No. 017-001-00474-0 or Summary Report: Stock No. 017-001-00473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-783-3238). ELIGIBILITY Applications may be submitted by domestic and foreign, for-profit and non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. Foreign applicants are not eligible for First Independent Research Support and Transition (FIRST) (R29) Awards. MECHANISM OF SUPPORT Research support may be requested through applications for a regular research project grant (R01), FIRST Award (R29), exploratory/developmental grant (R21), and small grant (R03). An applicant for an R01 may request support for up to five years. In FY 1995, the average total cost per year for new R01s funded by the NIAAA was approximately $200,000. Because the nature and scope of the research proposed in response to this RFA may vary, it is anticipated that the size of an award will vary also. FIRST Award applications must be for five years. Total direct costs for the five-year period may not exceed $350,000 or $100,000 in any one budget period. Small grants (R03) and exploratory/developmental grants (R21) are limited to two years for up to $50,000/year and $70,000/year, respectively, for direct costs. FIRST Awards, small grants and exploratory/developmental grants cannot be renewed, but grantees may apply for R01 support to continue research on the same topics. Potential applicants for FIRST Awards (R29), small grants (R03), and exploratory/developmental grants (R21) should obtain copies of the specific announcement for these programs from the National Clearinghouse for Alcohol and Drug Information, P.O. Box 2345, Rockville, MD 20852, telephone (301) 468-2600 or 1-800-729-6686. Investigators submitting applications that exceed $500,000 for direct costs in any one year must contact program staff prior to submitting an application. Applicants may also submit applications for Investigator-Initiated Interactive Research Project Grants (IRPG) (refer to PA-94-086, Vol. 23, No. 28, July 29, 1994). Interactive Research Project Grants require the coordinated submission of related research project grants (R01) and, to a limited extent, FIRST Award (R29) applications from investigators who wish to collaborate on research, but do not require extensive shared physical resources. These applications must share a common theme and describe the objectives and scientific importance of the interchange of, for example, ideas, data, and materials among the collaborating investigators. A minimum of two independent investigators with related research objectives may submit concurrent, collaborative, cross-referenced individual R01 and R29 applications. Applicants may be from one or several institutions. Further information on these and other grant mechanisms may be obtained from the program staff listed under INQUIRIES. FUNDS AVAILABLE It is estimated that $2 million in total costs will be available to support approximately 8 to 10 grants under this RFA. This level of support is dependent on the receipt of a sufficient number of applications of high scientific merit. Although this program is provided for in the financial plan of NIAAA, the award of grants pursuant to this RFA is also contingent upon the availability of funds. The earliest possible award date is July 1, 1996. RESEARCH OBJECTIVES Background Behavioral Research During the past decade many lines of converging data have suggested that alcohol and tobacco consumption are correlated. For example, smokers consume two times as much alcohol per capita as do non- smokers (Carmody et al., 1985) and their risk of excessive drinking is also twice that of non-smokers, a relationship that holds across a broad range of demographic variables (Henningfield et al., 1990; Johnson and Jennison, 1992). Alcoholism itself is estimated as 10 to 14 times more prevalent among those who smoke than those who do not (DiFranza and Guerrera, 1990). In addition, heavy drinking tends to be associated with heavy smoking with 85 percent of currently drinking alcoholics smoking daily. Although smoking has substantially declined in the United States to approximately 30 percent of adults it has diminished very little among alcoholics. Co-occurrence of smoking and excessive drinking has important treatment implications. For example, previous or current problems with alcohol and alcohol treatment bodes negatively for success in smoking cessation (Bobo et al., 1987; DiFranza and Guerrera, 1990; Sandor, 1991). On the other hand, smoking cessation prior to formal alcoholism treatment (Miller et al., 1983) appears to improve subsequent drinking outcome. Conversely, reducing drinking appears to improve the prospects for successful smoking cessation (Burling et al., 1982). Curiously, participation in a stop-smoking program conducted during the course of alcoholism treatment was found to enhance maintenance of sobriety, even though the intervention had little impact on smoking behavior itself (Burling et al., 1991). Discontinuation of smoking and long-term abstinence from drinking are also associated. Alcoholics who maintain sobriety longer have been reported as more successful in smoking cessation (Bobo et al., 1987; Hughes, 1993). Similarly, relapse to drinking may prompt smoking relapse (Shiffman et al., 1985; Sees and Clark, 1993). Several pharmacologic and behavioral mechanisms have been proposed to explain the association between smoking and drinking. At a pharmacologic level some degree of cross-tolerance seems to occur between nicotine and alcohol as sympathetic nervous system agents, each of which has both depressant and stimulant effects. Second, conjoint use of the two substances may also be due to accelerated metabolism of one substance following ingestion of the other. Third, nicotine and alcohol may somewhat counteract the aversive effects of each other, while potentiating reinforcing effects. Basic Science Administration of both alcohol and nicotine together to laboratory animals alters the responses to either drug when administered alone. For example, prior exposure to a low dose of nicotine increases alcohol consumption, whereas a high dose decreases consumption (Gauvin, Morre and Holloway, 1993). Animals respond more for lateral hypothalamic stimulation after nicotine treatment and less after ethanol treatment, compared to controls (Schaefer and Michael, 1992). However, when both agents are given together, responding is higher than after nicotine alone suggesting that alcohol is enhancing the reinforcing properties of nicotine. In discriminative stimulus studies, nicotine enhances the alcohol-like effects of nicotine in alcohol-preferring rats compared to non-preferring rats (Gordon, Meehan and Schecter, 1993). Further evidence of interactions between alcohol and nicotine derives from comparative sensitivity and cross-tolerance studies suggesting that the sensitivities to alcohol and nicotine are related. Mice selectively bred for alcohol sensitivity are also more sensitive to nicotine compared to alcohol-insensitive mice. In addition, alcohol- sensitive mice rendered tolerant to alcohol are also tolerant to nicotine (de Fiebre and Collins, 1993; Luo, Marks and Collins, 1994 and Majchrzak and Dilsaver, 1992) and nicotine-tolerant, alcohol- sensitive mice display cross-tolerance to alcohol (Collins et al., 1993). These effects are not observed in alcohol-insensitive mice. In other studies, nicotine can antagonize the motor incoordinating effect of alcohol (Dar and Bowman, 1994), whereas a nicotinic receptor antagonist partially blocks increased locomotor activity induced by alcohol (Blomqvist, Soderpalm and Engel, 1992). To better understand the treatment implications of alcohol and tobacco co-dependence, it is necessary to determine the mechanism of interaction of these two agents and how the actions are modified when both drugs are co-administered. Several lines of evidence suggest that although alcohol and nicotine have different molecular structures, they have actions in common. For example, both substances stimulate the release of dopamine in the nucleus accumbens, (Imperato and Di Chiara, 1986a, 1986b) an area of the brain involved with the reinforcing properties of drugs. A role for dopamine is also suggested by the observation that blockade of dopamine receptors increases both alcohol and nicotine intake (Gauvin, et al, 1993; Dawe et al, 1995) . Acetaldehyde is a pyrolysis product of tobacco and has been suggested to play a role in the reinforcing effects of alcohol. The rapid transport of acetaldehyde in an unmetabolized and undiluted form from the lungs through the heart to the brain may enhance the reinforcing properties of smoking. Areas of Research Interest The following list of topics is intended only to illustrate NIAAA interests; topics not specified should not be viewed as excluded from consideration. The primary objective of the RFA is to enhance the efficacy of treatment for nicotine addicted, alcohol dependent patients. To that end, research studies are solicited in the following areas. Research is needed to determine the conditions under which tobacco use serves as a salient risk factor for alcohol relapse. Research suggests several hypothesized mechanisms for the linkage in conjoint alcohol-tobacco use. Studies are needed to more clearly specify these putative mechanisms and understand their interactions. Studies are needed that identify the optimal sequencing of alcohol and smoking cessation in treatment programs. Studies are needed that investigate the use of new/existing pharmacologic agents as adjuncts to alcohol and smoking cessation and in the maintenance of abstinence. Our understanding of treatment issues would be advanced by the identification of the cellular and molecular mechanisms that underlie initiation, maintenance and relapse in conjoint alcohol and tobacco consumption. Studies that seek to advance the transfer of basic research findings toward treatment intervention applications are expressly encouraged. Research is needed that elucidates factors that underlie the joint vulnerability to alcohol and nicotine dependence. Research is needed to develop common assessment methodologies for alcohol and tobacco dependence that will lead to improved treatment efficacy. Research is needed to determine the extent to which alcohol acts through nicotinic receptors and other receptors and whether chronic nicotine exposure can alter those actions. Research is needed using gene knockout technology against the nicotinic receptor, examine the interactions of alcohol and nicotine. Studies are needed that clarify the nature of the discriminative stimuli for alcohol and nicotine and how these stimuli interact. Studies are needed to determine whether conditioned cues associated with smoking enhance alcohol reinforcement. Studies are needed that assess the role of acetaldehyde in alcohol- nicotine interactions. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This new policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43) and supersedes and strengthens the previous policies (Concerning the Inclusion of Women in Study Populations, and Concerning the Inclusion of Minorities in Study Populations) which have been in affect since 1990. The new policy contains some provisions that are substantially different from the 1990 policies. All investigators proposing research involving human subjects should read the "NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research," which have been published in the Federal Register of March 28, 1994 (FR 59 14508-14513) and in the NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994. Investigators also may obtain copies of the policy from the program staff listed under INQUIRIES. Program staff may also provide additional relevant information concerning the policy. LETTER OF INTENT Prospective applicants are asked to submit, by October 18, 1995, a letter of intent that includes a descriptive title of the proposed research, the name, address, and telephone number of the Principal Investigator, the identities of other key personnel and participating institutions, and the number of title of the RFA in response to which the application may be submitted. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows NIAAA staff to estimate the potential review workload and avoid conflict of interest in the review. The letter of intent is to be sent to: RFA: AA-95-005 Office of Scientific Affairs National Institute on Alcohol Abuse and Alcoholism Willco Building, Suite 409 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 FAX: (301) 443-6077 APPLICATION PROCEDURES The research grant application form PHS 398 (rev. 5/95) is to be used in applying for these grants. These forms are available at most institutional offices of sponsored research; from the Office of Grants Information, Division of Research Grants, National Institutes of Health, 6701 Rockledge Drive, Room 3032, MSC 7762, Bethesda, MD 20892, telephone 301-710-0267; and from the NIAAA program administrators listed under INQUIRIES. The RFA label available in the PHS 398 (rev. 5/95) application form must be affixed to the bottom of the face page of the application. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. In addition, the RFA title and number must be typed on line 2a of the face page of the application form and the YES box must be marked. Page limits and limits on size of type are strictly enforced. Applications for the FIRST award (R29) must include at least three sealed letters of reference attached to the face page of the original application. FIRST award (R29) applications submitted without the required number reference letters will be considered incomplete and will be returned without review. Submit a signed, typewritten original of the application, including the Checklist, and three signed, photocopies in one package to: DIVISION OF RESEARCH GRANTS NATIONAL INSTITUTES OF HEALTH 6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710 BETHESDA, MD 20892-7710 BETHESDA, MD 20817 (for express mail) At the time of submission, two additional copies of the application must also be sent to: Mark Green, Ph.D. Office of Scientific Affairs National Institute on Alcohol Abuse and Alcoholism Willco Building, Suite 409 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 (20852 for express mail) Applications must be received by November 21, 1995. If an application is received after that date, it will be returned to the applicant without review. The Division of Research Grants (DRG) will not accept any application in response to this RFA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. The DRG will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of substantial revisions of applications already reviewed, but such applications must be prepared as a revised application and include an introduction addressing the previous critique. REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed for completeness by DRG and for responsiveness by the NIAAA. Incomplete applications will be returned to the applicant without further consideration. If the application is not responsive to the RFA, DRG staff will contact the applicant to determine whether to return the application to the applicant or submit it for review in competition with unsolicited applications at the next review cycle. Applications that are complete and responsive to the RFA will be evaluated for scientific and technical merit by an appropriate peer review group convened by the Institute in accordance with the review criteria stated below. As part of the initial merit review, a process (triage) may be used by the initial review group in which applications will be determined to be competitive or non-competitive based on their scientific merit relative to other applications received in response to the RFA. Applications judged to be competitive will be discussed and be assigned a priority score. Applications determined to be non- competitive will be withdrawn from further consideration and the Principal Investigator and the official signing for the applicant organization will be notified. The second level of review will be provided by the appropriate National Advisory Council or Board. Review Criteria Criteria to be used in the scientific and technical merit review of alcohol research grant applications will include the following: 1. The scientific, technical, or medical significance and originality of the proposed research. 2. The appropriateness and adequacy of the experimental approach and methodology proposed to carry out the research. 3. The adequacy of the qualifications (including level of education and training) and relevant research experience of the principal investigator and key research personnel. 4. The availability of adequate facilities, general environment for the conduct of the proposed research, other resources, and collaborative arrangements necessary for the research. 5. The reasonableness of budget estimates and duration in relation to the proposed research. 6. Adequacy of plans to include both genders and minorities and their subgroups as appropriate for the scientific goals of the research. Plans for the recruitment and retention of subjects will also be evaluated. 7. Where applicable, the adequacy of procedures to protect or minimize effects on human and animal subjects and the environment. The review criteria for Small Grants (R03), Exploratory/Developmental Grants (R21), and FIRST Awards (R29) are contained in their program announcements. AWARD CRITERIA Applications recommended for approval by the National Advisory Council on Alcohol Abuse and Alcoholism will be considered for funding on the basis of the overall scientific and technical merit of the proposal as determined by peer review, NIAAA programmatic needs and balance, and the availability of funds. INQUIRIES Inquiries concerning this RFA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding treatment aspects of proposed research to: Joanne Fertig, Ph.D. Division of Clinical and Prevention Research National Institute on Alcohol Abuse and Alcoholism Willco Building, Suite 402 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 Telephone: (301) 443-0796 FAX: (301) 443-8744 Email: jfertig@willco.niaaa.nih.gov Direct inquiries regarding the neuroscience and behavioral aspects of proposed research to: Walter Hunt, Ph.D. Division of Basic Research National Institute on Alcohol Abuse and Alcoholism Willco Building, Suite 402 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 Telephone: (301) 443-4223 FAX: (301) 594-0673 Email: whunt@willco.niaaa.nih.gov Direct inquiries regarding fiscal matters to: Joseph Weeda Office of Planning and Resource Management National Institute on Alcohol Abuse and Alcoholism Willco Building, Suite 504 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 Telephone: (301) 443-4703 FAX: (301) 443-3891 Email: jweeda@willco.niaaa.nih.gov AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance, No. 93.273. Awards are made under the authorization of the Public Health Service Act, Sections 301 and 464H, and administered under the PHS policies and Federal Regulations at Title 42 CFR Part 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The PHS strongly encourages all grant and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routing education, library, day care, health care or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the american people. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |